Company Performance Metrics
IDM Insight are accelerating the discovery and refinement of clinical treatments using AI. The technology is designed to simplify and optimise the protocol development process. Raising £1m.
OVERVIEW The landscape of clinical trials is evolving rapidly, with increasing demands for efficiency, cost-effectiveness, and inclusivity in research.
ClinCraft, developed in partnership with Nvidia and AWS, simplifies the clinical trial protocol development process, enabling researchers to leverage advanced algorithms and data analytics. ClinCraft provides real-time insights and personalized recommendations tailored to specific research needs.
ClinCraft integrates with IDM Insights Clinical Trial Database, a source of up-to-date clinical trial records and regulatory requirements. This ensures researchers have access to vital information necessary for informed decision-making, to improve the overall efficacy of clinical studies.
EXECUTIVE SUMMARY • In partnership with NVIDIA and AWS. • Integration with a comprehensive database of clinical trial records and global regulatory requirements. • Advanced analytics and predictive modelling to identify trends and optimize protocols. • Focus on clinical, regulatory, site & patient inclusivity, ensuring diverse representation in clinical trials. • www.idm-insight.com BACKGROUND IDM Insight, are creating an ecosystem where innovative technologies and scientific expertise work hand in hand. They are ensuring that every researcher has access to the cutting-edge technologies necessary to improve their processes and outcomes. Rooted in its core values of compassion, integrity, collaboration, and innovation, IDM Insight strive to pave the way for a healthier future, where AI-driven advancements lead to meaningful breakthroughs in drug development.
IDM Insight are currently seeking investment partners who share the vision of advancing medical research and improving patient care.
Join us on the ground floor of what is going to be a spectacular journey.